ID: ALA2163900

Max Phase: Preclinical

Molecular Formula: C35H48N10O3

Molecular Weight: 656.84

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCc1ccccc1

Standard InChI:  InChI=1S/C35H48N10O3/c36-28(14-9-21-42-35(39)40)31(46)45-30(22-24-16-18-27(19-17-24)26-12-5-2-6-13-26)33(48)44-29(15-7-8-20-41-34(37)38)32(47)43-23-25-10-3-1-4-11-25/h1-6,10-13,16-19,28-30H,7-9,14-15,20-23,36H2,(H,43,47)(H,44,48)(H,45,46)(H4,37,38,41)(H4,39,40,42)/t28-,29-,30-/m0/s1

Standard InChI Key:  OZCKRVTUFZBKFF-DTXPUJKBSA-N

Associated Targets(non-human)

Stomach 551 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Duodenum 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 8163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 656.84Molecular Weight (Monoisotopic): 656.3911AlogP: 1.43#Rotatable Bonds: 19
Polar Surface Area: 237.12Molecular Species: BASEHBA: 6HBD: 10
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.37CX Basic pKa: 11.89CX LogP: 0.83CX LogD: -3.93
Aromatic Rings: 3Heavy Atoms: 48QED Weighted: 0.05Np Likeness Score: -0.04

References

1. Karstad R, Isaksen G, Wynendaele E, Guttormsen Y, De Spiegeleer B, Brandsdal BO, Svendsen JS, Svenson J..  (2012)  Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration.,  55  (14): [PMID:22720778] [10.1021/jm3002058]

Source